rs768771267

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2

The ENST00000609883.3(RTL5):​c.1264G>C​(p.Asp422His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000266 in 1,200,834 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 10 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000027 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.000027 ( 0 hom. 9 hem. )

Consequence

RTL5
ENST00000609883.3 missense

Scores

1
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 1.45

Publications

1 publications found
Variant links:
Genes affected
RTL5 (HGNC:29430): (retrotransposon Gag like 5)
NHSL2 (HGNC:33737): (NHS like 2) Predicted to enable calcium ion binding activity. Predicted to be involved in cell differentiation. Predicted to be active in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08857635).
BS2
High Hemizygotes in GnomAdExome4 at 9 gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NHSL2NM_001013627.3 linkc.281-1802C>G intron_variant Intron 1 of 7 ENST00000633930.2 NP_001013649.2 Q5HYW2-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTL5ENST00000609883.3 linkc.1264G>C p.Asp422His missense_variant Exon 1 of 1 6 ENSP00000476792.1 Q5HYW3
NHSL2ENST00000633930.2 linkc.281-1802C>G intron_variant Intron 1 of 7 5 NM_001013627.3 ENSP00000488668.1 Q5HYW2-1

Frequencies

GnomAD3 genomes
AF:
0.0000274
AC:
3
AN:
109535
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000571
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000166
AC:
3
AN:
180899
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000370
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000266
AC:
29
AN:
1091299
Hom.:
0
Cov.:
32
AF XY:
0.0000252
AC XY:
9
AN XY:
356935
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26287
American (AMR)
AF:
0.00
AC:
0
AN:
35172
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19321
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30168
South Asian (SAS)
AF:
0.00
AC:
0
AN:
53918
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40487
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4119
European-Non Finnish (NFE)
AF:
0.0000347
AC:
29
AN:
835973
Other (OTH)
AF:
0.00
AC:
0
AN:
45854
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000274
AC:
3
AN:
109535
Hom.:
0
Cov.:
21
AF XY:
0.0000315
AC XY:
1
AN XY:
31785
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29971
American (AMR)
AF:
0.00
AC:
0
AN:
10303
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2618
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3487
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2439
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5813
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
236
European-Non Finnish (NFE)
AF:
0.0000571
AC:
3
AN:
52509
Other (OTH)
AF:
0.00
AC:
0
AN:
1479
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.525
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000130
Hom.:
1
Bravo
AF:
0.0000340
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Aug 26, 2022
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1264G>C (p.D422H) alteration is located in exon 1 (coding exon 1) of the RGAG4 gene. This alteration results from a G to C substitution at nucleotide position 1264, causing the aspartic acid (D) at amino acid position 422 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
14
DANN
Benign
0.95
DEOGEN2
Benign
0.0027
T
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.40
T
M_CAP
Benign
0.0034
T
MetaRNN
Benign
0.089
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.4
PrimateAI
Benign
0.28
T
Sift4G
Pathogenic
0.0010
D
Polyphen
0.92
P
Vest4
0.14
MVP
0.014
ClinPred
0.068
T
GERP RS
3.2
Varity_R
0.060
gMVP
0.059
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs768771267; hg19: chrX-71350127; API